ALNYLAM PHARMACEUTICALS, INC. (ALNY)
About ALNYLAM PHARMACEUTICALS, INC.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $3.7B
- Net income
- $313.7M
- Total assets
- $5.0B
- Market cap
- $36.3B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $36.3B
- Shares outstanding
- 160.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 28, 2004
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price
- Profitable — net income of $313.7M in FY2025.
- Trading 54% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ALNYLAM PHARMACEUTICALS, INC..
Write a review
News about ALNYLAM PHARMACEUTICALS, INC.
News & sentiment via Polygon.io
Alnylam Pharmaceuticals, Inc.: frequently asked questions
Is Alnylam Pharmaceuticals, Inc. an American company?
Yes — Alnylam Pharmaceuticals, Inc. is an American company. Alnylam Pharmaceuticals, Inc. is incorporated in Delaware, United States and headquartered in Cambridge, Massachusetts. Its legal-entity record reports no foreign parent — the company is independently American-owned.
Where is Alnylam Pharmaceuticals, Inc. incorporated?
Alnylam Pharmaceuticals, Inc. is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.
Who owns Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.
Is Alnylam Pharmaceuticals, Inc. traded on a US stock exchange?
Yes — Alnylam Pharmaceuticals, Inc. trades under the ticker ALNY on the NASDAQ.
Where is Alnylam Pharmaceuticals, Inc. headquartered?
Alnylam Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.
Is Alnylam Pharmaceuticals, Inc. publicly traded?
Yes — Alnylam Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ALNY on the NASDAQ.
What does Alnylam Pharmaceuticals, Inc. do?
Alnylam Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
